HNGE — Hinge Health, Inc.

Hinge Health Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Q4 Revenue: $171 million, up 46% year-over-year.
• Full Year 2025 Revenue: $588 million, a 51% increase from 2024.
• Calculated Billings: $671 million for the last 12 months, a 44% year-over-year growth.
• Gross Margin: 85% in Q4 and 83% for the full year, reflecting operational efficiency.
• Operating Margin: 28% in Q4 and 20% for the full year, showing significant improvement from previous years.
• Free Cash Flow: $62 million in Q4 (36% margin) and $180 million for the full year (31% margin).
• Rule of 40 Metric: 81% for the full year, indicating strong growth and profitability.

2. Strategic Updates and Business Highlights

• Market Reach: Expanded to nearly 25 million contracted lives across over 2,800 clients, a 25% increase year-over-year.
• AI Initiatives: Significant advancements in AI tools improved care delivery efficiency; member satisfaction scores reached an all-time high.
• HingeSelect Launch: A high-performance provider network now available to several hundred thousand eligible lives, with promising early data showing cost savings and improved member outcomes.
• Sales Success: Exceptional sales season with 4.8 million net new contracted lives added, including significant wins from competitors.

3. Forward Guidance and Outlook

• Q1 2026 Revenue Guidance: Expected to be between $171 million and $173 million, representing 39% year-over-year growth.
• Full Year 2026 Revenue Guidance: Projected between $732 million and $742 million, indicating 25% growth at the midpoint.
• Operating Profit Guidance: Anticipated non-GAAP income from operations of $151 million to $156 million for 2026, with a 21% margin.

4. Challenges and Points of Concern

• Yield Expectations: Yield is expected to remain flat in 2026, which may limit revenue growth potential despite strong member engagement.
• Competitive Pressures: The market is seeing consolidation among competitors, though Hinge Health has maintained a strong competitive win rate.
• HingeSelect Revenue Impact: No significant revenue contribution from HingeSelect expected until 2027, indicating a longer timeline for realizing its potential.

5. Notable Q&A Insights

• Competitive Moats: CEO Daniel Perez emphasized Hinge's competitive advantages beyond software, including proprietary data and established distribution channels.
• Member Engagement: First-year cohorts showed improved engagement metrics, suggesting potential for continued growth in yield.
• TAM Expansion: Discussions on expanding beyond physical therapy into preventive care were noted, but the focus remains on capturing existing market opportunities.
• M&A Strategy: Hinge Health is open to tuck-in acquisitions but is primarily focused on organic growth and enhancing its existing offerings.

Overall, Hinge Health reported a strong performance in 2025, with significant growth in revenue and member engagement, while also outlining a cautious but optimistic outlook for 2026 amidst competitive pressures and strategic investments in new initiatives.